Cargando…
Muscarinic Receptor Type-3 in Hypertension and Cholinergic-Adrenergic Crosstalk: Genetic Insights and Potential for New Antihypertensive Targets
Autores principales: | Alves-Lopes, Rhéure, Neves, Karla B., Touyz, Rhian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pulsus Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499128/ https://www.ncbi.nlm.nih.gov/pubmed/30954389 http://dx.doi.org/10.1016/j.cjca.2019.02.003 |
Ejemplares similares
-
Oxidative Stress: A Unifying Paradigm in Hypertension
por: Touyz, Rhian M., et al.
Publicado: (2020) -
Role of PARP and TRPM2 in VEGF Inhibitor‐Induced Vascular Dysfunction
por: Neves, Karla B., et al.
Publicado: (2023) -
Vasoprotective effects of NOX4 are mediated via polymerase and transient receptor potential melastatin 2 cation channels in endothelial cells
por: Alves-Lopes, Rheure, et al.
Publicado: (2023) -
Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications
por: Harvey, Adam, et al.
Publicado: (2016) -
Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment
por: Soukup, Ondrej, et al.
Publicado: (2017)